Latest reports
| Published | Report | Description | |
|---|---|---|---|
| 13.04.2026 | ESPI 9/2026 | Estimated value of the amount of financing transferred as part of the Demerger | Download |
| 10.04.2026 | ESPI 8/2026 | Introduction of ordinary series A and B bearer shares to be traded on the Main Market of the Warsaw Stock Exchange | Download |
| 09.04.2026 | ESPI 7/2026 | Receipt of notification pursuant to Article 69 of the Act on Public Offering – change in the status of ownership of the Issuer’s shares | Download |
Upcoming events
15.04.2026
First day of listing of Syn2bio shares on the regulated market of the WSE
Latest news
Syn2bio now on the stock exchange
- Corporate news
- Investor relations
The division of Synektik is complete – the court has registeredthe issue of Syn2bio shares
- Corporate news
- Investor relations
Synektik shareholders have unanimously approved the division of the company and spinoff of the cardiotracer project to Syn2bio
- Corporate news
- Investor relations
Investor relations
phone: +48 22 327 09 10
e-mail: ir@syn2bio.pl